Marguerite Thompson-O’Neal
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Marguerite Thompson-O’Neal
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Purdue Pharma (Canada)
 Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Purdue Pharma (Canada) manufactures and markets pharmaceutical products. It products for the treatment of pain, respiratory disease, gastrointestinal disorders, and infection control. The firm include laxatives, bronchodilators, antiseptics, and analgesics. Purdue Pharma is headquartered in Pickering, Canada
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Marguerite Thompson-O’Neal tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| MEDIPHARM LABS CORP. | Agricultural Commodities/Milling | Chief Operating Officer Chief Executive Officer | |
| University of Toronto | College/University | Undergraduate Degree Masters Business Admin | |
Legacy Hotels Real Estate Investment Trust
 Legacy Hotels Real Estate Investment Trust Real Estate Investment TrustsFinance Part of LGY Acquisition LP, Legacy Hotels Real Estate Investment Trust is a Real Estate Investment Trust/REIT. The company is based in Toronto, Canada. Founded in 1997. | Real Estate Investment Trusts | Chief Executive Officer | |
| Wilfrid Laurier University | College/University | Undergraduate Degree | |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| ELUTIA INC. | Biotechnology | Director/Board Member | |
HighCape Partners Management LLC
 HighCape Partners Management LLC Investment ManagersFinance HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut.. | Investment Managers | Consultant / Advisor | |
Science Creates Ventures
 Science Creates Ventures Investment ManagersFinance Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom. | Investment Managers | Consultant / Advisor | |
| GlaxoWellcome /Pharmocology Unit/ | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Guelph | College/University | Undergraduate Degree | |
Impopharma, Inc.
 Impopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Impopharma, Inc. engages in developing and testing of pulmonary and nasal drug delivery systems and ophthalmic, otic, and dermal products. The company was founded by Hanna Piskorz and Harold Wulffhart in 1996 and is headquartered in Concord, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
| NEPTUNE WELLNESS SOLUTIONS INC. | Pharmaceuticals: Other | Chief Operating Officer | |
| Kellogg School of Management | College/University | Masters Business Admin | |
Baxter AG
 Baxter AG Medical DistributorsDistribution Services Part of Baxter International, Inc., Baxter AG is a Swiss company that is uniting with Hillrom to improve healthcare outcomes and broaden access to care in various settings. The company is based in Volketswell, Switzerland. Baxter emphasizes the importance of corporate governance in today's business environment, where investor and public trust in the company is no longer solely based on financial performance or products and services. | Medical Distributors | Corporate Officer/Principal | |
| McGill University | College/University | Doctorate Degree | |
HighCape Capital Acquisition Corp. II
 HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member | |
| Concordia University | College/University | Masters Business Admin | |
10607410 Canada, Inc.
 10607410 Canada, Inc. Medical/Nursing ServicesHealth Services 10607410 Canada, Inc. engages in the research and development of cannabis products. The firm also produces cannabis drug formulations and dose delivery systems. The company was founded by Bruce Linton in 2016 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Chief Operating Officer | |
| ANTIBE THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Order of Pharmacists of Quebec | Corporate Officer/Principal | ||
| UNIVERSAL IBOGAINE INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Montréal | College/University | Doctorate Degree | |
Mundipharma Research Ltd.
 Mundipharma Research Ltd. BiotechnologyHealth Technology Part of Pacific Moon Corp., Mundipharma Research Ltd. is a British company that engages in research and development of medications. The company is based in Cambridge, UK. The company was founded in 2006. The CEO is Julie Ducharme. | Biotechnology | Chief Executive Officer | |
Mundipharma Research Verwaltungs GmbH
 Mundipharma Research Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services Mundipharma Research Verwaltungs GmbH provides management services for the pharmaceutical industry. The private company is based in Berlin, Germany. The CEOs of the German company are Stuart David Baker, Julie Ducharme, Maximilian Carl-Alexander Göth. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Cardiff | College/University | Doctorate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Biotechnology | Director/Board Member | |
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Chief Executive Officer | |
| NANOVIRICIDES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Portsmouth | College/University | Undergraduate Degree | |
| TALON INTERNATIONAL, INC. | Miscellaneous Manufacturing | Chief Executive Officer | |
| University of Utah | College/University | Graduate Degree | |
Global Dimension Capital, Inc.
 Global Dimension Capital, Inc. Financial ConglomeratesFinance Global Dimension Capital, Inc. offers a wide range of consulting services with the necessary tools and expertise to help grow business. Its services include mergers & acquisitions, repositioning & rebranding and financing services. The company is headquartered in Toronto, Canada. | Financial Conglomerates | Chief Executive Officer | |
Balboa Investments, Inc.
 Balboa Investments, Inc. Real Estate DevelopmentFinance Balboa Investments, Inc. develops and manages properties and assets. The private company is based in Baton Rouge, LA and has subsidiaries in Canada. | Real Estate Development | Director/Board Member | |
| HOLLOWAY LODGING CORPORATION | Hotels/Resorts/Cruise lines | Director/Board Member | |
| ALPHA PEAK LEISURE INC. | Financial Conglomerates | Director/Board Member | |
Triovest Realty Advisors, Inc.
 Triovest Realty Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Triovest Realty Advisors, Inc. operates as a commercial real estate advisory services. It offers property management, asset management, and leasing services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| BSR REAL ESTATE INVESTMENT TRUST | Real Estate Investment Trusts | Chairman | |
| Talon International Development, Inc. | Chief Executive Officer | ||
Fairmont Hotels & Resorts, Inc.
 Fairmont Hotels & Resorts, Inc. Hotels/Resorts/Cruise linesConsumer Services Fairmont Hotels & Resorts, Inc. engages in the business of owning and operating hotels and resorts. The company's portfolio includes historic icons, resorts and city center properties. Its amenities include accommodation rooms and suites, restaurants, spas, golf courses, meeting and wedding facilities. The company was founded in 1907 and is headquartered in Toronto, Canada. | Hotels/Resorts/Cruise lines | Corporate Officer/Principal | |
AEW Mexico Co.
 AEW Mexico Co. Real Estate DevelopmentFinance AEW Mexico Co. provides real estate consulting, private equity, and investment banking services. The private company is based in Dallas. The American company was founded by Neil J. Labatte. | Real Estate Development | Founder | |
| SKYLINE INVESTMENTS INC. | Hotels/Resorts/Cruise lines | Director/Board Member | |
| Nhl Alumni Association | Chairman | ||
TFB, Inc.
 TFB, Inc. Medical SpecialtiesHealth Technology Part of H.U. Group Holdings, Inc., TFB, Inc. is a Japanese company that manufactures and sells medical equipment and medicine. The company is based in Toshima-ku, Japan. | Medical Specialties | Director/Board Member | |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Canada | 26 |
| Stati Uniti | 16 |
| Regno Unito | 7 |
| Svizzera | 2 |
| Germania | 2 |
Settori
| Consumer Services | 15 |
| Health Technology | 14 |
| Finance | 12 |
| Commercial Services | 6 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 30 |
| Corporate Officer/Principal | 17 |
| Chief Executive Officer | 11 |
| Independent Dir/Board Member | 8 |
| President | 7 |
Contatti più connessi
| Insiders | |
|---|---|
| Neil Labatte | 24 |
| David Colpman | 15 |
| Mark Day | 8 |
| David J. Mayers | 7 |
| Rami Batal | 7 |
| David Pidduck | 5 |
| John Sebben | 4 |
| Julie Ducharme | 4 |
| Grant D. Perry | 1 |
- Borsa valori
- Insiders
- Marguerite Thompson-O’Neal
- Connessioni Società
